Kalium Chloratum Wzf

Potassium chloride, the active ingredient in Kalium Chloratum Wzf, is an electrolyte supplement presented as an intravenous solution for intravenous use. It restores normal serum potassium levels and corrects hypokalemia in patients who have potassium loss due to diuretics, gastrointestinal disorders, or other causes. Rapid intravenous administration allows timely correction of serum potassium deficits.

GNH USA supplies Kalium Chloratum Wzf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to strict quality standards and provides reliable logistics for global healthcare facilities.

Kalium Chloratum Wzf is used to replace potassium in conditions characterized by electrolyte depletion.

- Hypokalemia: restores normal serum potassium levels to prevent complications. - Diuretic‑induced potassium loss: replenishes potassium lost through renal excretion. - Gastrointestinal potassium loss: corrects deficits caused by vomiting or diarrhea. - Prevention of low‑potassium cardiac arrhythmias: maintains cardiac electrical stability by normalizing potassium concentrations.

Adverse reactions may occur with intravenous potassium chloride administration.

Common Side Effects: - Infusion site irritation or pain. - Mild hyperkalemia causing transient muscle weakness. - Nausea or vomiting. - Headache.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Anaphylactic or severe allergic reaction. - Thrombophlebitis at the infusion site. - Sudden hypotension. - Life‑threatening electrolyte imbalance.

Use Kalium Chloratum Wzf with careful clinical monitoring.

- Serum potassium monitoring: check levels before, during, and after infusion. - Renal impairment: adjust infusion rate and total dose. - Cardiac disease: avoid rapid infusion to prevent arrhythmias. - Hyperkalemia: contraindicated in patients with already elevated potassium. - Concomitant potassium‑sparing agents: assess risk of additive hyperkalemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride may interact with several medications.

Major Interactions (Avoid): - ACE inhibitors or ARBs: can amplify hyperkalemia risk. - Potassium‑sparing diuretics (e.g., spironolactone): additive potassium increase. - NSAIDs: may reduce renal potassium excretion.

Moderate Interactions (Monitor Closely): - Digoxin: altered serum potassium can affect drug toxicity. - Insulin: insulin drives potassium into cells, potentially lowering serum levels.